Applied Therapeutics Inc. (NASDAQ: APLT)
$5.93
+0.3800 ( +6.85% ) 1.1M
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Market Data
Open
$5.93
Previous close
$5.55
Volume
1.1M
Market cap
$678.75M
Day range
$4.83 - $6.03
52 week range
$1.18 - $9.39
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 09, 2024 |
def | Proxies and info statements | 5 | Apr 22, 2024 |
ars | Annual reports | 1 | Apr 22, 2024 |
8-k | 8K-related | 16 | Apr 15, 2024 |
3 | Insider transactions | 2 | Apr 15, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |
pre | Proxies and info statements | 5 | Apr 11, 2024 |
8-k | 8K-related | 13 | Mar 29, 2024 |
3 | Insider transactions | 2 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |